ATE424448T1 - Testverfahren für zustandsabhängige calciumkanal- agonisten/-antagonisten - Google Patents

Testverfahren für zustandsabhängige calciumkanal- agonisten/-antagonisten

Info

Publication number
ATE424448T1
ATE424448T1 AT03774653T AT03774653T ATE424448T1 AT E424448 T1 ATE424448 T1 AT E424448T1 AT 03774653 T AT03774653 T AT 03774653T AT 03774653 T AT03774653 T AT 03774653T AT E424448 T1 ATE424448 T1 AT E424448T1
Authority
AT
Austria
Prior art keywords
methods
antagonists
condition
test methods
calcium channel
Prior art date
Application number
AT03774653T
Other languages
English (en)
Inventor
Menghang Xia
Thomas Connolly
Paul Bennett
Charles Cohen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE424448T1 publication Critical patent/ATE424448T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03774653T 2002-10-10 2003-10-09 Testverfahren für zustandsabhängige calciumkanal- agonisten/-antagonisten ATE424448T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41801702P 2002-10-10 2002-10-10

Publications (1)

Publication Number Publication Date
ATE424448T1 true ATE424448T1 (de) 2009-03-15

Family

ID=32094136

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03774653T ATE424448T1 (de) 2002-10-10 2003-10-09 Testverfahren für zustandsabhängige calciumkanal- agonisten/-antagonisten

Country Status (6)

Country Link
US (1) US20060014206A1 (de)
EP (1) EP1560915B1 (de)
AT (1) ATE424448T1 (de)
CA (1) CA2501233A1 (de)
DE (1) DE60326482D1 (de)
WO (1) WO2004033647A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1581558A2 (de) * 2003-01-07 2005-10-05 Neuromed Technologies, Inc. Fluoreszenz-basiertes t-typ ionenkanal-testverfahren
WO2006055927A2 (en) * 2004-11-17 2006-05-26 The Cleveland Clinic Foundation Pathogenic gene and protein associated with paroxysmal dyskinesia and epilepsy
US10052497B2 (en) 2005-07-22 2018-08-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
EP1919497B1 (de) 2005-07-22 2020-02-12 The Board of Trustees of the Leland Stanford Junior University Lichtaktivierter kationenkanal und dessen verwendung
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US9238150B2 (en) 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
US8926959B2 (en) 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
GB0520405D0 (en) * 2005-10-07 2005-11-16 Imp College Innovations Ltd Biological agents and method
KR100716103B1 (ko) 2005-10-28 2007-05-09 한국과학기술연구원 Ｔ-형 칼슘 채널 차단제의 세포 기반 고효율 검색 방법
WO2008086470A1 (en) 2007-01-10 2008-07-17 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8401609B2 (en) 2007-02-14 2013-03-19 The Board Of Trustees Of The Leland Stanford Junior University System, method and applications involving identification of biological circuits such as neurological characteristics
WO2008106694A2 (en) 2007-03-01 2008-09-04 The Board Of Trustees Of The Leland Stanford Junior University Systems, methods and compositions for optical stimulation of target cells
US10434327B2 (en) 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US10035027B2 (en) 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
JP5801188B2 (ja) 2008-04-23 2015-10-28 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 標的細胞を光刺激するためのシステム、方法、および組成物
MY152003A (en) 2008-05-29 2014-08-15 Univ Leland Stanford Junior Cell line, system and method for optical control of secondary messengers
CA2728238C (en) 2008-06-17 2019-03-12 M. Bret Schneider Methods, systems and devices for optical stimulation of target cells using an optical transmission element
MY162929A (en) 2008-06-17 2017-07-31 Univ Leland Stanford Junior Apparatus and methods for controlling cellular development
US9101759B2 (en) 2008-07-08 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
NZ602416A (en) 2008-11-14 2014-08-29 Univ Leland Stanford Junior Optically-based stimulation of target cells and modifications thereto
US20100330607A1 (en) * 2009-06-24 2010-12-30 Photoswitch Biosciences, Inc. Photoswitch-enabled ion channel assay system
US20110144028A1 (en) * 2009-12-11 2011-06-16 Vinod Sharma Modulating cellular electrophysiology
EP2547762B1 (de) 2010-03-17 2018-04-25 The Board of Trustees of the Leland Stanford Junior University Lichtempfindliche ionendurchgangsmoleküle
US9522288B2 (en) 2010-11-05 2016-12-20 The Board Of Trustees Of The Leland Stanford Junior University Upconversion of light for use in optogenetic methods
WO2012061679A2 (en) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
CA2816968C (en) 2010-11-05 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Optically-controlled cns dysfunction
CA2816972C (en) 2010-11-05 2019-12-03 The Board Of Trustees Of The Leland Stanford Junior University Control and characterization of memory function
EP2635111B1 (de) 2010-11-05 2018-05-23 The Board of Trustees of the Leland Stanford Junior University Stabilisierte opsin-proteine mit stufenfunktion und verwendungsverfahren dafür
WO2012061688A1 (en) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of reward-related behaviors
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
ES2724803T3 (es) 2011-12-16 2019-09-16 Univ Leland Stanford Junior Polipéptidos opsinas y métodos de utilización de los mismos
CN104363961B (zh) 2012-02-21 2017-10-03 斯坦福大学托管董事会 用于治疗盆底神经源性病症的组合物和方法
KR20150108853A (ko) * 2013-01-10 2015-09-30 타우 쎄라퓨틱스 엘엘씨 암의 치료를 위한 t-타입 칼슘 채널 억제제
JP6594854B2 (ja) 2013-03-15 2019-10-23 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 行動状態の光遺伝学的制御方法
US9636380B2 (en) 2013-03-15 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of inputs to the ventral tegmental area
JP6549559B2 (ja) 2013-04-29 2019-07-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 標的細胞における活動電位の光遺伝学的調節のための装置、システム及び方法
JP6621747B2 (ja) 2013-08-14 2019-12-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 疼痛を制御するための組成物及び方法
WO2016209654A1 (en) 2015-06-22 2016-12-29 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
WO2020193446A1 (en) * 2019-03-22 2020-10-01 Westfälische Wilhelms-Universität Münster Catsper-activity-test for determining male infertility

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043457A (en) * 1990-04-17 1991-08-27 Allergan, Inc. 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents
US5429921A (en) * 1988-04-04 1995-07-04 The Salk Institute Biotechnology/Industrial Assoc. Inc. Assays for agonists and antagonists of recombinant human calcium channels
US6096514A (en) * 1988-04-04 2000-08-01 Sibia Neurosciences, Inc. Human calcium channel compositions and methods
US5876958A (en) * 1988-04-04 1999-03-02 Sibia Neurosciences, Inc. Assays of cells expressing human calcium channels containing α1 β subunits
US5851824A (en) * 1988-04-04 1998-12-22 Sibia Neurosciences, Inc. Human calcium channel α-1C/α-1D, α-2, β-1, and γsubunits and cells expressing the DNA
US6090623A (en) * 1993-08-11 2000-07-18 Merck & Co., Inc. Recombinant human calcium channel β4 subunits
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5661035A (en) 1995-06-07 1997-08-26 The Regents Of The University Of California Voltage sensing by fluorescence resonance energy transfer
US6117990A (en) * 1999-04-06 2000-09-12 Synaptic Pharmaceutical Corporation DNA encoding SNORF1 receptor
US7399599B2 (en) * 2000-07-10 2008-07-15 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods

Also Published As

Publication number Publication date
US20060014206A1 (en) 2006-01-19
DE60326482D1 (de) 2009-04-16
EP1560915B1 (de) 2009-03-04
EP1560915A4 (de) 2006-11-15
WO2004033647A2 (en) 2004-04-22
EP1560915A2 (de) 2005-08-10
CA2501233A1 (en) 2004-04-22
WO2004033647A3 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
ATE424448T1 (de) Testverfahren für zustandsabhängige calciumkanal- agonisten/-antagonisten
MX2010004630A (es) Metodo y aparato para monitoreo de formacion de coagulo de fibrina espacial.
DK1483576T3 (da) Hidtil ukendt fremgangsmåde til detektion og analysering af proteininteraktioner in vivo
EP1802157A4 (de) Verfahren zur bereitstellung eines modulations- und kodierungsbetriebs zur verwendung bei multicast-servia-macro-diversity
NO20082351L (no) Screeninganalyse med hoy gjennomgang for TRPM5 ionekanalen
DE60141455D1 (de) Faims apparatur und verfahren unter verwendung eines trägergases von gemischter zusammensetzung
GB2427468B (en) Cell separation device and method for the detection of EpCAM positive cells
TW200622950A (en) Methods of monitoring the concentration of an analyte
NO20081375L (no) Analyser og fremgangsmater som benytter biomarkorer
ATE468534T1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
ATE490466T1 (de) Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen
DK1502102T3 (da) Forbindelser og fremgangsmåder til analysering af proteomet
ATE418729T1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
WO2003006103A3 (en) Electrical field stimulation of eukaryotic cells
DE602007000887D1 (de) Reagens, Ausstattung und Verfahren zur Probenanalyse
ATE437370T1 (de) Pharmakodynamische tests mit durchflusszytometrie
AR054483A1 (es) Metodo y aparato de medicion de la densidad de un componente en un flujo multicomponente
IL156149A0 (en) A method for measuring the total concentration of carbon monoxide and hydrocarbons in oxygen by means of ion mobility spectrometry
DE60139056D1 (de) Blutzellen-Detektor, Blutanalysegerät und Blutanalyseverfahren unter Verwendung des Detektors
TW200722746A (en) Method for detecting sample supply condition, and analyzer
ATE554391T1 (de) Verfahren zur analyse von metaboliten
WO2009082533A3 (en) Method of identification of petroleum compounds using frequency mixing on surfaces
DE602005001465D1 (de) Vorrichtung und Verfahren zur Entnahme von Proben
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties